Loading
HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$2.73
−HK$0.005 · -0.18%
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Latest quote
HK$2.73
−HK$0.005 · -0.18%
Regular session · HKT · Market data may be delayed.
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Day range
Current HK$2.73
52-week range
Current HK$2.73
Regular session · HKT · Market data may be delayed.
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Day range
Current HK$2.73
52-week range
Current HK$2.73
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.145
2025 complete year+45.0% since 2021
2026 partial: HK$0.03
HK$0.10
2,021
HK$0.13
2,022
HK$0.15
2,023
HK$0.18
2,024
HK$0.145
2,025
HK$0.03
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 10, 2026 | HK$0.055Semi-Annual | Sep 14, 2026 | Sep 24, 2026 |
Dividend | May 20, 2026 | HK$0.03Semi-Annual | May 21, 2026 | Jun 4, 2026 |
Dividend | Sep 11, 2025 | HK$0.05Semi-Annual | Sep 12, 2025 | Sep 26, 2025 |
Dividend | May 20, 2025 | HK$0.095Semi-Annual | May 21, 2025 | Jun 3, 2025 |
Dividend | Sep 12, 2024 | HK$0.08Semi-Annual | Sep 13, 2024 | Sep 27, 2024 |
Dividend | May 21, 2024 | HK$0.10Semi-Annual | May 22, 2024 | Jun 4, 2024 |
Ex-dividend Sep 10, 2026
HK$0.055
Semi-Annual
Record Sep 14, 2026 · Payment Sep 24, 2026
Ex-dividend May 20, 2026
HK$0.03
Semi-Annual
Record May 21, 2026 · Payment Jun 4, 2026
Ex-dividend Sep 11, 2025
HK$0.05
Semi-Annual
Record Sep 12, 2025 · Payment Sep 26, 2025
Ex-dividend May 20, 2025
HK$0.095
Semi-Annual
Record May 21, 2025 · Payment Jun 3, 2025
Ex-dividend Sep 12, 2024
HK$0.08
Semi-Annual
Record Sep 13, 2024 · Payment Sep 27, 2024
Ex-dividend May 21, 2024
HK$0.10
Semi-Annual
Record May 22, 2024 · Payment Jun 4, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core MSCI Emerging Markets ETFIEMG5.7M0.00%161.18B USD0.09%$83.65+1.65%
Vanguard Total International Stock ETFVXUS5M0.00%646.2B USD0.05%$88.41+0.50%
Vanguard FTSE Emerging Markets ETFVWO4.84M0.00%162.3B USD0.06%$61.44+0.74%
Avantis Emerging Markets Equity ETFAVEM3.19M0.01%28.22B USD0.33%$96.81+1.52%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.1M0.01%13.6B USD0.06%$161.34+0.42%
iShares Core MSCI Total International Stock ETFIXUS843.96K0.00%60.45B USD0.07%$98.71+0.57%
Dimensional World ex U.S. Core Equity 2 ETFDFAX428.61K0.00%12.55B USD0.28%$38.61+0.44%
Avantis Emerging Markets Value ETFAVES391.4K0.03%1.54B USD0.36%$67.85+0.82%iShares Core MSCI Emerging Markets ETFIEMGVanguard Total International Stock ETFVXUSVanguard FTSE Emerging Markets ETFVWOAvantis Emerging Markets Equity ETFAVEMVanguard FTSE All-World ex-US Small-Cap ETFVSSiShares Core MSCI Total International Stock ETFIXUSDimensional World ex U.S. Core Equity 2 ETFDFAXAvantis Emerging Markets Value ETFAVESAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
